Clinical Trials Directory

Trials / Unknown

UnknownNCT01149161

Extent of Central Lymph Node Dissection in Papillary Thyroid Microcarcinoma

Sentinel Lymph Node Biopsy in the Thyroid Carcinoma; Randomized, Prospective Study

Status
Unknown
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
2,000 (estimated)
Sponsor
Samsung Medical Center · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

Occult lymph node metastasis is common in micro papillary thyroid cancer. However, the role of lymph node dissection in the treatment of microPTC remains controversial. The investigators want to investigate the usefulness routine central dissection and sentinel lymph node biopsy in prognosis of micro PTC. This is a prospective randomized control study. The investigators started this study from May of 2009 and this study will be continued until Dec. 2011.

Detailed description

The investigators will assign all patients to three groups; no dissection group (Group I), sentinel lymph node biopsy only group (Group II) and routine central neck dissection group (Group III). At first, to know the necessity of routine central neck node dissection for micro PTC,the investigators will compare the result of group I and group III. Additionally, the investigators can analyze the usefulness of sentinel lymph node biopsy for substitution of routine central neck node dissection for micro PTC.

Conditions

Interventions

TypeNameDescription
PROCEDURERoutine central neck dissectionLevel VI neck node dissection during thyroid operation

Timeline

Start date
2009-05-01
Primary completion
2017-12-01
Completion
2020-12-01
First posted
2010-06-23
Last updated
2016-04-21

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01149161. Inclusion in this directory is not an endorsement.